Cataract & Refractive

A preview of this year's ESCRS congress in Barcelona.

Oertli has developed a new phaco tip, easyTip2.2mm, based on the design of the CO-MICS 2. It uses a new fluidics concept with a high vacuum setting and a wide infusion path, creating a strong axially directed flow.

The Food and Drug Administration (FDA) has warned that doctors promoting LASIK may not be informing consumers correctly about potential risks involved.

Implanting toric IOLs during phacoemulsification.

Examining why wavefront guided ablation provides the best optical results in the majority of patients.

Does transient IOP elevation prevent doctors from submitting patients to refractive procedures?

A comparison of two silicone lenses; the Staar KS3-Ai pre-loaded and the Tecnis Z9002

According to a report in the Journal of the American Medical Association patients taking tamsulosin for benign prostrate enlargement within 14 days of cataract surgery may have an increased risk of complications.

The cataract surgery technology landscape including pipeline products at varying development stages comes under scrutiny in a new report released this month.

Oculentis will present its presbyopia correcting LENTIS Mplus IOL at DOC 2009 in Nuremberg to an expert audience. It claims the lens features a completely new approach in multi-focal lens technology.

Visiogen is reporting significant progress in the development of the Synchrony IOL, including the completion of the US phase III study, the formation of Visiogen Europe GmbH and the commencement of commercialization in Europe.

A study comparing pain perception during cataract surgery with and without the use of lidocaine.

A comparative study of three presbyopia-correcting lenses demonstrates that aspheric lenses offer superior performance over other designs.

Assessing whether certain surgical methods can minimize exposing the eye to oxidation during phacoemulsification/

A common problem associated with cataract surgery is deviation from target refraction. This study examines whether variable IOL diameter can result in improvements.

“As we move into the 21st century the role of the IOL will evolve allowing better outcomes in cataract surgery and find new roles in surgery to improve vision such as through the treatment of presbyopia.”

Is there a difference in intraocular scatter in eyes with mono and mulifocal IOLs?

We look into whether pIOLs stay in position after implantation in the long term, preventing damage to intraocular tissues and retain a good quality of vision.

The Visante omni is the first system to combine OCT and Placido disk technologies, providing comprehensive anterior and posterior topography for improved patient selection and care.

Scientists at New York's Rochester University say that playing violent video games may improve contrast sensitivity, which is often impaired by amblyopia.

In what is believed to be the first comprehensive eye disease study among urban pre-schoolers, investigators writing in the April issue of the journal Ophthalmology report that while vision problems are rare, they are more common than once thought.

Dr Randall Olson looks at the results of head-to-head testing of the latest phacoemulsification machines.

Patients in need of visual corrections whose vision is not affected by existing high-order aberrations (HOAs) may have an alternative to wavefront treatment using an aberration-free method.

Many patients undergoing phacoemulsification want more than simply cataract extraction. Dr Detlev Breyer says that advances in surgical technique and IOL design have made it possible to satisfy most patients' requirements.

The trend for microincisional procedures is escalating. Dr Boris Malyugin compares SICS and C-MICS.

Dr Gilles Lesieur asks: Do disposable microincision knives or diamond knives provide patients with the best postoperative visual outcome?

BD OcuSeal Liquid Ocular Bandage, a fully synthetic protective barrier to be used for post-surgical, post-traumatic and non-traumatic ocular conditions, has been launched in Europe by BD Medical?Ophthalmic Systems.

When treating post-phacorefractive keratectomy (PRK) discomfort, there are no significant differences in either safety or efficacy between bromfenac twice-daily and ketorolac four times daily, according to a study published in the February issue of the Journal of Refractive Surgery.

According to research analysts it is estimated that as little as five percent of a topically applied drug ever reaches the intraocular tissues due to drug loss as the result of tearing, lacrimal fluid-eye barriers, and blood-ocular barriers.

The eyecare nutritional supplement market is worth $43.4 million and is projected to grow to $87.4 million within five years, according to research by Frost & Sullivan.